Acasti Pharma
Stock Forecast, Prediction & Price Target

Acasti Pharma Financial Estimates

Acasti Pharma Revenue Estimates

Acasti Pharma EBITDA Estimates

Acasti Pharma Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027 3/31/2028
Revenue
 
% change YoY
$196K
 
N/A
$0
 
-100%
$0
 
0%
Avg: $1.21M
Low: $1.21M
High: $1.21M
avg. 0%
Avg: $52.87M
Low: $52.87M
High: $52.87M
avg. 4243.50%
Avg: $0
Low: $0
High: $0
avg. -100%
Net Income
 
% change YoY
$-19.67M
 
N/A
$-9.81M
 
50.10%
$-12.85M
 
-30.89%
Avg: $-25.96M
Low: $-13.14M
High: $-13.14M
avg. -102.04%
Avg: $-11.41M
Low: $-4.64M
High: $-4.64M
avg. 56.03%
Avg: $7.63M
Low: $7.63M
High: $7.63M
avg. 166.84%
EBITDA
 
% change YoY
$-12.30M
 
N/A
$-19.98M
 
-62.42%
$-11.30M
 
43.46%
Avg: $730.38K
Low: $730.38K
High: $730.38K
avg. 106.46%
Avg: $31.72M
Low: $31.72M
High: $31.72M
avg. 4243.51%
Avg: $0
Low: $0
High: $0
avg. -100%
EPS
 
% change YoY
-$7.96
 
N/A
-$1.6
 
79.89%
-$1.35
 
15.62%
Avg: -$1.38
Low: -$1.38
High: -$1.38
avg. -2.20%
Avg: -$0.49
Low: -$0.49
High: -$0.49
avg. 64.67%
Avg: $0.8
Low: $0.8
High: $0.8
avg. 264.33%
Operating Expenses
 
% change YoY
$10.83M
 
N/A
$15.34M
 
41.56%
$11.30M
 
-26.32%
Avg: $9.24M
Low: $9.24M
High: $9.24M
avg. -18.23%
Avg: $401.35M
Low: $401.35M
High: $401.35M
avg. 4243.50%
Avg: $0
Low: $0
High: $0
avg. -100%

FAQ

What is Acasti Pharma stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 40.27% in 2026-2028.

We have gathered data from 1 analysts. Their low estimate is -13.14M, average is -25.96M and high is -13.14M.

What is Acasti Pharma stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 1414.50% in 2026-2028.

We have gathered data from 1 analysts. Their low revenue estimate is $1.21M, average is $1.21M and high is $1.21M.

What is Acasti Pharma stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 108.93% in 2026-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.38, average is -$1.38 and high is $-1.37.